William H. Carson

CIK 1824280 · last filed 2026-05-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$369.3K

Companies

3

Total Filings

30

Lifetime Open-Market Net

$374.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANNX Director 78,405 $4.71 $369.3K $374.1K 24 2026-05-13
Decibel Therapeutics, Inc. (DBTX) Delisted Director 0 $4.91 $0 $0 4 2023-09-25
Prevail Therapeutics Inc. (PRVL) Delisted Director $0 1 2020-09-11

Recent Filings · Page 2 of 3

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-06-09 ANNX Grant (A) $0 EDGAR
2024-12-04 ANNX Buy (P) +3,200 $17.1K EDGAR
2024-10-02 ANNX Buy (P) +3,200 $19.1K EDGAR
2024-09-04 ANNX Buy (P) +3,200 $17.5K EDGAR
2024-08-05 ANNX Buy (P) +3,200 $20.0K EDGAR
2024-07-02 ANNX Buy (P) +3,200 $16.0K EDGAR
2024-06-07 ANNX Grant (A) $0 EDGAR
2024-06-05 ANNX Buy (P) +3,200 $15.5K EDGAR
2024-05-03 ANNX Buy (P) +3,200 $15.0K EDGAR
2024-04-10 ANNX Buy (P) +3,200 $19.4K EDGAR
Showing 1120 of 30
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.